Ascletis Pharma Stock

Ascletis Pharma Employees 2024

Ascletis Pharma Employees

285

Ticker

1672.HK

ISIN

KYG0520K1094

WKN

A2JRKN

In 2024, Ascletis Pharma employed 285 people, a 0% change from the 285 number of employees in the previous year.

Ascletis Pharma Aktienanalyse

What does Ascletis Pharma do?

Ascletis Pharma Inc is a bio-pharmaceutical company that was founded in Hong Kong in 2009. The focus of the company is the development and marketing of drugs for the treatment of infectious diseases and cancer. The business model of Ascletis Pharma Inc is based on research and development, as well as sales and marketing activities. The company collaborates closely with academic institutions and clinical researchers to discover and develop new drugs. In recent years, Ascletis has received various awards and recognitions for its products. The company's portfolio includes various areas, such as the treatment of viral infectious diseases like hepatitis B and C infections. They have also developed drugs for the treatment of solid tumors, such as gastric cancer and liver cancer. Alongside medical research, Ascletis also conducts various sales and marketing activities. The company works with partners to market its products worldwide. In summary, Ascletis Pharma Inc is an emerging bio-pharmaceutical company specializing in the development of drugs for the treatment of infectious diseases and cancer. The business model is based on research and development, as well as sales and marketing of products. The company has various divisions and offers a variety of products. Ascletis has experienced continuous growth in recent years and is considered one of the most innovative companies in the industry. Ascletis Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Ascletis Pharma's Employee Base

Ascletis Pharma's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Ascletis Pharma's operational capacity and future potential.

Year-to-Year Comparison

Assessing Ascletis Pharma's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Ascletis Pharma's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Ascletis Pharma’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Ascletis Pharma stock

How many employees does Ascletis Pharma have this year?

Ascletis Pharma has 285 undefined employees this year.

How many employees did Ascletis Pharma have compared to the previous year?

Compared to the previous year, Ascletis Pharma had 0% more employees.

What impact did the number of employees have on the company Ascletis Pharma?

The number of employees has a direct impact on the efficiency and productivity of Ascletis Pharma. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Ascletis Pharma?

The number of employees can also have an impact on investors of Ascletis Pharma, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Ascletis Pharma affect the company?

An increase in equity of Ascletis Pharma can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Ascletis Pharma's equity affect the company?

A reduction in equity of Ascletis Pharma can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Ascletis Pharma?

Some factors that can influence the equity of Ascletis Pharma include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Ascletis Pharma so important for investors?

The equity of Ascletis Pharma is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Ascletis Pharma influence the company?

The number of employees at Ascletis Pharma can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Ascletis Pharma evolved in recent years?

In recent years, the number of employees at Ascletis Pharma has changed by 0.

How many employees does Ascletis Pharma currently have?

Ascletis Pharma currently has 285 undefined employees.

Why is the number of employees important for investors of Ascletis Pharma?

The number of employees is important for investors of Ascletis Pharma as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Ascletis Pharma take to change the number of employees?

To change the number of employees, Ascletis Pharma can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Ascletis Pharma pay?

Over the past 12 months, Ascletis Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ascletis Pharma is expected to pay a dividend of 0 CNY.

What is the dividend yield of Ascletis Pharma?

The current dividend yield of Ascletis Pharma is .

When does Ascletis Pharma pay dividends?

Ascletis Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Ascletis Pharma?

Ascletis Pharma paid dividends every year for the past 0 years.

What is the dividend of Ascletis Pharma?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Ascletis Pharma located?

Ascletis Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Ascletis Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ascletis Pharma from 10/3/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 10/3/2024.

When did Ascletis Pharma pay the last dividend?

The last dividend was paid out on 10/3/2024.

What was the dividend of Ascletis Pharma in the year 2023?

In the year 2023, Ascletis Pharma distributed 0 CNY as dividends.

In which currency does Ascletis Pharma pay out the dividend?

The dividends of Ascletis Pharma are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Ascletis Pharma

Our stock analysis for Ascletis Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ascletis Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.